- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/17 - LymphocytesB-cellsT-cellsNatural killer cellsInterferon-activated or cytokine-activated lymphocytes
Patent holdings for IPC class A61K 35/17
Total number of patents in this class: 11662
10-year publication summary
|
476
|
677
|
1035
|
1237
|
1401
|
1599
|
1346
|
1305
|
897
|
20
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1136 |
501 |
| The Regents of the University of California | 20324 |
278 |
| The Trustees of the University of Pennsylvania | 4380 |
245 |
| Iovance Biotherapeutics, Inc. | 352 |
201 |
| Board of Regents, The University of Texas System | 5966 |
193 |
| Memorial Sloan-Kettering Cancer Center | 1980 |
180 |
| The Board of Trustees of the Leland Stanford Junior University | 6553 |
134 |
| Juno Therapeutics, Inc. | 463 |
116 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2921 |
115 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 993 |
108 |
| The General Hospital Corporation | 4800 |
96 |
| Baylor College of Medicine | 977 |
91 |
| City of Hope | 1008 |
88 |
| Autolus Limited | 264 |
84 |
| Cellectis | 406 |
83 |
| Dana-Farber Cancer Institute, Inc. | 2620 |
83 |
| Regents of the University of Minnesota | 2750 |
75 |
| Kite Pharma, Inc. | 424 |
71 |
| Immunitybio, Inc. | 481 |
71 |
| Novartis AG | 10506 |
70 |
| Other owners | 8779 |